{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:31Z","timestamp":1792166251294,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/ejcn.2017.102","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T06:01:08Z","timestamp":1498629668000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases"],"prefix":"10.1038","volume":"72","author":[{"given":"T","family":"Ml\u010doch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Puda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Je\u0161ina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lhot\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160","family":"\u0160t\u011brbov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Dole\u017eal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"BFejcn2017102_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, Spronsen JFv, Levy LH . Phenylketonuria. Lancet 2010; 376: 1417\u20131427.","journal-title":"Lancet"},{"key":"BFejcn2017102_CR2","unstructured":"Honz\u00edk T, Zeman J (2013). D\u011bdi\u010dn\u00e9 metabolick\u00e9 poruchy v d\u011btsk\u00e9m v\u011bku, Institut postgradu\u00e1ln\u00edho vzd\u011bl\u00e1v\u00e1n\u00ed ve zdravotnictv\u00ed. Available at \n                    http:\/\/www.vzdelavani-zdravotniku.cz\/autorska-dila\/lekari\/dedicne_poruchy%20metabolismu\/dedicne_poruchy%20metabolismu.html\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR3","unstructured":"Neonatal screening in the Czech Republic. The actual epidemiological statistics and the complete list of IMD included in the screening. Available at \n                    http:\/\/www.novorozeneckyscreening.cz\/vysledky-ns-2012-19-10-2015-131436\n                    \n                  ; \n                    http:\/\/www.novorozeneckyscreening.cz\/ov-co-je-novorozenecky-screening\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR4","unstructured":"Orphanet, the portal for rare disease. Available at \n                    http:\/\/www.orpha.net\/consor\/cgi-bin\/Disease_Search.php?lng=EN&data_id=173&Disease_Disease_Search_diseaseGroup=homocystinuria&Disease_Disease_Search_diseaseType=Pat&Disease(s)\/group%20of%20diseases=Classic-homocystinuria&title=Classic-homocystinuria&search=Disease_Search_Simple\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-90-481-9485-8_23","volume":"686","author":"T Pampols","year":"2010","unstructured":"Pampols T . Inherited metabolic rare disease in rare disease epidemiology. Adv Exp Med Biol 2010; 686: 397\u2013431.","journal-title":"Adv Exp Med Biol"},{"key":"BFejcn2017102_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","volume":"112","author":"MK Camp","year":"2014","unstructured":"Camp MK, Parisi AM, Acosta PB, Berry TG, Bilder AD, Blau N et al. Phenylketonuria scientific research review konference: state of the science and future research needs. Mol Genet Metab 2014; 112: 87\u2013122.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1750-1172-8-191","volume":"8","author":"ST Hagedorn","year":"2013","unstructured":"Hagedorn ST, Berkel P, Hammerschmidt G, Lhotakova M, Saludes PR . Requirements for a minimum standard of care for phenylketonuria: the patients\u2019 perspective. Orphanet J Rare Dis 2013; 8: 191.","journal-title":"Orphanet J Rare Dis"},{"key":"BFejcn2017102_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","volume":"92","author":"SE Waisbren","year":"2007","unstructured":"Waisbren SE, Noel K, Fahrbach K, Cella C, Frame D, Dorenbaum A et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab 2007; 92: 63\u201370.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.psym.2012.04.010","volume":"53","author":"A Bone","year":"2012","unstructured":"Bone A, Kuehl KA, Angelino FA . A neuropsychiatric perspective of phenylketonuria I: overview of phenylketonuria and its neuropsychiatric sequelae. Psychosomatics 2012; 53: 517\u2013523.","journal-title":"Psychosomatics"},{"key":"BFejcn2017102_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","volume":"30","author":"D Modan-Moses","year":"2007","unstructured":"Modan-Moses D, Vered I, Schwarz G, Anikster Y, Abraham S, Segev R et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 2007; 30: 202\u2013208.","journal-title":"J Inherit Metab Dis"},{"key":"BFejcn2017102_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF00710427","volume":"18","author":"RO Fisch","year":"1995","unstructured":"Fisch RO, Chang PN, Weisberg S, Guldbert P, Guttler F, Tsai MY . Phenylketonuric patients decades after diet. J Inherit Metab Dis 1995; 18: 347\u2013353.","journal-title":"J Inherit Metab Dis"},{"key":"BFejcn2017102_CR12","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1007\/PL00014260","volume":"155","author":"R Koch","year":"1996","unstructured":"Koch R, Azen C, Friedman EG, Fishler K, Baumann-Frischling C, Lin T . Care of the adult with pnhenylketonuria. Eur J Pediatr 1996; 155: S90\u2013S92.","journal-title":"Eur J Pediatr"},{"key":"BFejcn2017102_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/B:BOLI.0000028781.94251.1f","volume":"27","author":"V Leuzzi","year":"2004","unstructured":"Leuzzi V, Pansini M, Sechi E, Chiarotti F, Carducci C, Levi G et al. Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis 2004; 27: 115\u2013125.","journal-title":"J Inherit Metab Dis"},{"key":"BFejcn2017102_CR14","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1007\/PL00014388","volume":"159","author":"P Burgard","year":"2000","unstructured":"Burgard P . Development of intelligence in early treated phenylketonuria. Eur J Pediatr 2000; 159: S74\u2013S79.","journal-title":"Eur J Pediatr"},{"key":"BFejcn2017102_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ymgme.2013.09.001","volume":"110","author":"M Cleary","year":"2013","unstructured":"Cleary M, Trefz F, Muntau AC, Feillet F, Spronsen JF, Burlina A et al. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes. Mol Genet Metab 2013; 110: 418\u2013423.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","volume":"40","author":"AMA Morris","year":"2017","unstructured":"Morris AMA, Ko\u017eich V, Santra S, Andria G, Ben-Omran MIT, Chakrapani BA et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis 2017; 40: 49\u201374.","journal-title":"J Inherit Metab Dis"},{"key":"BFejcn2017102_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"RM Baumgartner","year":"2014","unstructured":"Baumgartner RM, H\u00f6rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman AK et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis 2014; 9: 130.","journal-title":"Orphanet J Rare Dis"},{"key":"BFejcn2017102_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","volume":"112","author":"MD Frazier","year":"2014","unstructured":"Frazier MD, Allgeier C, Homer C, Marriage BJ, Ogata B, Rohr F et al. Nutrition management guidelines for maple syrup urine disease: an evidence- and concensus-based approach. Mol Genet Metab 2014; 112: 210\u2013217.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-8-8","volume":"8","author":"C Laet de","year":"2013","unstructured":"Laet de C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 2013; 8: 8.","journal-title":"Orphanet J Rare Dis"},{"key":"BFejcn2017102_CR20","unstructured":"Urea Cycle Treatment Guidelines. Rare Diseases Clinical Research Network. Available at \n                    http:\/\/www.rarediseasesnetwork.org\/cms\/ucdc\/Healthcare-Professionals\/Urea-Cycle-Treatment-Guidelines\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR21","unstructured":"Blau N, Spronsen JF, Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N et al. (eds). Physician\u2019s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Disease. Springer-Verlag: Berlin Heidelberg, 2014."},{"issue":"7","key":"BFejcn2017102_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ejcn.2016.54","volume":"70","author":"M J Pena","year":"2016","unstructured":"Pena MJ, Almeida MF, Dam E, Ahring K, Belanger-Quintana, Dokoupil K et al. Protein substitutes for phenylketonuria in Europe: access and nutritional composition. Eur J Clin Nutr 2016 70: 785\u2013789.","journal-title":"European Journal of Clinical Nutrition"},{"key":"BFejcn2017102_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ymgme.2013.05.003","volume":"109","author":"I Eijgelshoven","year":"2013","unstructured":"Eijgelshoven I, Demirdas S, Smith TA, Jeanni MTL, Latour S, Bosch AM . The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab 2013; 109: 237\u2013242.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ymgme.2011.12.004","volume":"105","author":"A Belanger-Quintana","year":"2012","unstructured":"Belanger-Quintana A, Dokoupil K, Gokmen-Ozel H, Lammardo AM, MacDonald A, Motzfeldt K et al. Diet in phenylketonuria: a snapshot of special dietary costs and reimbursement systems in 10 international centers. Mol Genet Metab 2012; 105: 390\u2013394.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"BFejcn2017102_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10545-016-9995-0","volume":"40","author":"Lin Wang","year":"2016","unstructured":"Wang L, Zou H, Ye F, Wang K, Li X, Chen Z et al. Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study. J Inherit Metab Dis; 40: 369\u2013376.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BFejcn2017102_CR26","unstructured":"Honz\u00edk T, Zeman J, Ko\u017eich V (2014). D\u011bdi\u010dn\u00e9 poruchy metabolismu in Kate\u0159ina Kub\u00e1\u010dkov\u00e1 a kol., Vz\u00e1cn\u00e1 onemocn\u011bn\u00ed v kostce, Mlad\u00e1 fronta, a,s, Praha."},{"key":"BFejcn2017102_CR27","unstructured":"Guidelines of the National Centre for Treatment of Inherited Metabolic Diseases (Institute of Inherited Metabolic Disorders, Charles University\u2013First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. Available at \n                    http:\/\/udmp.lf1.cuni.cz\/\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR28","unstructured":"Spronsen JF, Wegberg MJA, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch A et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 2017. Available at \n                    http:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213858716303205\n                    \n                  ."},{"key":"BFejcn2017102_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1541-4337.12057","volume":"13","author":"N Soltanizadeh","year":"2014","unstructured":"Soltanizadeh N, Mirmoghtadaie L . Strategies used in production of phenylalanine-free foods for PKU management. Compr Rev Food Sci Food Saf 2014; 13: 287\u2013299.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"BFejcn2017102_CR30","unstructured":"Exchange rates, cumulative averages. Czech National Bank. Available at \n                    http:\/\/www.cnb.cz\/cs\/financni_trhy\/devizovy_trh\/kurzy_devizoveho_trhu\/prumerne_mena.jsp?mena=EUR\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00431-014-2458-4","volume":"174","author":"FK Trefz","year":"2015","unstructured":"Trefz FK, Spronsen FJ, MacDonald A, Feillet F, Muntau CA, Belanger-Quintana A et al. Management of adult patients with phenylketonuria: survey results from 24 countries. Eur J Pediatr 2015; 174: 119\u2013127.","journal-title":"Eur J Pediatr"},{"key":"BFejcn2017102_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpeds.2013.12.015","volume":"164","author":"R Jahja","year":"2014","unstructured":"Jahja R, Huijbregts SCJ, Sonneville LMJ, Meere JJ, Spronsen JF . Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria. J Pediatr 2014; 164: 895\u2013899.e2.","journal-title":"J Pediatr"},{"key":"BFejcn2017102_CR33","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ymgme.2011.08.025","volume":"104","author":"F Trefz","year":"2011","unstructured":"Trefz F, Maillot F, Motzfeldt K, Schwarz M . Adult phenylketonuria outcome and management. Mol Genet Metab 2011; 104: S26\u2013S30.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR34","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","volume":"33","author":"J Albrecht","year":"2009","unstructured":"Albrecht J, Gerbade SF, Burgard P . Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta analysis. Neurosci Biobehav Rev 2009; 33: 414\u2013421.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFejcn2017102_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ymgme.2013.09.007","volume":"110","author":"Y Okano","year":"2013","unstructured":"Okano Y, Nagasaka H . Optimal serum phenylalanine for adult patients with phenylketonuria. Mol Genet Metab 2013; 110: 424\u2013430.","journal-title":"Mol Genet Metab"},{"key":"BFejcn2017102_CR36","unstructured":"Expenditure and household family statistics, Family Budget for the year 2015. Czech Statistical Office. Available at \n                    https:\/\/www.czso.cz\/csu\/czso\/vydani-a-spotreba-domacnosti-statistiky-rodinnych-uctu-domacnosti-podle-postaveni-osoby-v-cele-podle-velikosti-obce-prijmova-pasma-regiony-soudrznosti-2015\n                    \n                   (accessed 27 September 2016)."},{"key":"BFejcn2017102_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-015-0378-7","volume":"10","author":"MJ Pe\u0148a","year":"2015","unstructured":"Pe\u0148a MJ, Almeida MF, Dam E, Ahring K, Belanger-Quintana A, Dokoupil K et al. Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile. Orphanet J Rare Dis 2015; 10: 162.","journal-title":"Orphanet J Rare Dis"},{"key":"BFejcn2017102_CR38","first-page":"601","volume":"63","author":"D Proch\u00e1zkov\u00e1","year":"2008","unstructured":"Proch\u00e1zkov\u00e1 D, Jarkovsk\u00fd J, Vinohradsk\u00e1 H, Kone\u010dn\u00e1 P, Macha\u010dov\u00e1 L, Dole\u017eel Z . Fenylketonurie v dosp\u011blosti. \u010ceskoslovensk\u00e1 Pediatrie 2008; 63: 601\u2013605.","journal-title":"\u010ceskoslovensk\u00e1 Pediatrie"},{"key":"BFejcn2017102_CR39","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1651-2227.2011.02227.x","volume":"100","author":"G Cotugno","year":"2011","unstructured":"Cotugno G, Nicol\u00f3 R, Cappelletti S, Goffredo BM, Vici DC, Ciommo V . Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr 2011; 100: 1144\u20131149.","journal-title":"Acta Paediatr"},{"key":"BFejcn2017102_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ejcn.2010.258","volume":"65","author":"K Ahring","year":"2011","unstructured":"Ahring K, B\u00e9langer-Quintana A, Dokoupil K, Ozel-Gokmen H, Lammardo AM, MacDonald A et al. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres. Eur J Clin Nutr 2011; 65: 275\u2013278.","journal-title":"Eur J Clin Nutr"},{"issue":"Suppl 2","key":"BFejcn2017102_CR41","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","volume":"31","author":"M Bik-Multanowski","year":"2008","unstructured":"Bik-Multanowski M, Didycz B, Mozrzymas R, Nowacka M, Kaluzny L, Cichy W et al. Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 2008; 31 (Suppl 2): S415\u2013S418.","journal-title":"J Inherit Metab Dis"},{"key":"BFejcn2017102_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1046\/j.1365-2788.1999.43120176.x","volume":"43","author":"MCJ Brown","year":"1999","unstructured":"Brown MCJ, Guest JF . Economic impact of feeding a phenylalanine-restricted diet to adults with previously untreated phenylketonuria. J Intellect Disabil Res 1999; 43: 30\u201337.","journal-title":"J Intellect Disabil Res"},{"key":"BFejcn2017102_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10198-015-0759-9","volume":"18","author":"T Mlcoch","year":"2017","unstructured":"Mlcoch T, Klimes J, Fila L, V\u00e1vrov\u00e1 V, Skalick\u00e1 V, Turnovec M et al. Cost-of-illness analysis and regression modelling in cystic fibrosis: a retrospective prevalence-based study. Eur J Health Econ 2017; 18: 73\u201382.","journal-title":"Eur J Health Econ"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejcn2017102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejcn2017102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ejcn.2017.102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ejcn2017102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:50:34Z","timestamp":1684403434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejcn2017102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFejcn2017102"],"URL":"https:\/\/doi.org\/10.1038\/ejcn.2017.102","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]},"assertion":[{"value":"18 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RP and \u0160\u0160 are members of NSPKU and ML is a NSPKU volunteer. NSPKU receives sponsorship from several producers of food for special medical purposes, including low-protein food. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}